Cargando…

Data mining analyses for precision medicine in acromegaly: a proof of concept

Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL) is a must for personalized medicine. Although many biomarkers linked to SRL response have been identified, there is no consensus criterion on how to assign this pharmacologic treatment according to biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil, Joan, Marques-Pamies, Montserrat, Sampedro, Miguel, Webb, Susan M., Serra, Guillermo, Salinas, Isabel, Blanco, Alberto, Valassi, Elena, Carrato, Cristina, Picó, Antonio, García-Martínez, Araceli, Martel-Duguech, Luciana, Sardon, Teresa, Simó-Servat, Andreu, Biagetti, Betina, Villabona, Carles, Cámara, Rosa, Fajardo-Montañana, Carmen, Álvarez-Escolá, Cristina, Lamas, Cristina, Alvarez, Clara V., Bernabéu, Ignacio, Marazuela, Mónica, Jordà, Mireia, Puig-Domingo, Manel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148300/ https://www.ncbi.nlm.nih.gov/pubmed/35643771 http://dx.doi.org/10.1038/s41598-022-12955-2

Ejemplares similares

Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
por: Gil, Joan, et al.
Publicado: (2022)

Pasireotide in the Personalized Treatment of Acromegaly
por: Puig-Domingo, Manel, et al.
Publicado: (2021)

Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
por: Marques-Pamies, Montserrat, et al.
Publicado: (2023)

Preference of acromegaly patients for treatment attributes in Spain
por: Fajardo, Carmen, et al.
Publicado: (2023)

Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey
por: de Pablos-Velasco, Pedro, et al.
Publicado: (2019)

Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
por: Bernabéu, Ignacio, et al.
Publicado: (2020)

Prevalence of acromegaly in patients with symptoms of sleep apnea
por: Sesmilo, Gemma, et al.
Publicado: (2017)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
por: Biagetti, Betina, et al.
Publicado: (2022)

Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
por: Gil, Joan, et al.
Publicado: (2023)

Metabolic Fingerprint of Acromegaly and Its Potential Usefulness in Clinical Practice
por: Biagetti, Betina, et al.
Publicado: (2019)

SAT-LB078 Acromegaly Disease Activity According to ACRODAT® in Spain: ACROVAL Study
por: Marazuela, Monica, et al.
Publicado: (2019)

Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery
por: Alvarez-Escola, Cristina, et al.
Publicado: (2015)

Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study
por: Marazuela, Mónica, et al.
Publicado: (2021)

GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
por: Biagetti, Betina, et al.
Publicado: (2021)

Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
por: Biagetti, Betina, et al.
Publicado: (2021)

Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms
por: Biagetti, Betina, et al.
Publicado: (2022)

Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature
por: Araujo-Castro, Marta, et al.
Publicado: (2023)

Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
por: Simó-Servat, Olga, et al.
Publicado: (2012)

Genetics in Diabetic Retinopathy: Current Concepts and New Insights
por: Simó-Servat, Olga, et al.
Publicado: (2013)

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
por: Simó-Servat, Olga, et al.
Publicado: (2016)

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy
por: Sampedro, Joel, et al.
Publicado: (2019)

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
por: Chenlo, Miguel, et al.
Publicado: (2019)

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database
por: Petrossians, Patrick, et al.
Publicado: (2017)

Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours
por: García-Martínez, Araceli, et al.
Publicado: (2020)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2021)

Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
por: Planas, Alejandra, et al.
Publicado: (2022)

Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications
por: Ramos, Hugo, et al.
Publicado: (2023)

Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?
por: Ramos-Leví, Ana M., et al.
Publicado: (2019)

Acromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy
por: Sanz-Sapera, E, et al.
Publicado: (2019)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
por: Lamas, Cristina, et al.
Publicado: (2023)

Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
por: García-Martínez, Araceli, et al.
Publicado: (2018)

Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors
por: García-Martínez, Araceli, et al.
Publicado: (2020)

How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?
por: Torregrosa-Quesada, María Eugenia, et al.
Publicado: (2019)

Vertebral Fractures in Acromegaly: A Systematic Review
por: Sorohan, Madalina Cristina, et al.
Publicado: (2022)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia
por: Simó-Servat, Olga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mk3qdrejlibc2dslg8e644cja